Work

Advances in the development of personalized neoantigen therapies

Year: 2025

Type: article

Source: The Journal of Experimental Medicine

DOI: 10.1084/jem.20241234

Authors: Spencer E. Mirabile-Brightman, Lisa H. Butterfield

Institutions: La Jolla Institute for Immunology, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417177189

FWCI: 0.61

Cites: 119

Cited by: 2

Related to: